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Abstract
Systemic sclerosis (SSc) is a rare, chronic connective tissue disease with 
characteristic fibrosis of the skin, musculoskeletal system, and internal 
organs. It is a heterogeneous and polymorphic disorder, in which fatigue, sleep 
disturbances, stiffness, and joint pain are among the most significant clini-
cal symptoms. However, the presence of stiffening and thickening of the skin 
usually has a negative impact on the appearance of these patients, and the 
degree of  self-dissatisfaction can fundamentally interfere with their personality. 
 Self-consciousness and self-conception of the patient, accompanied by depres-
sion, can also be affected. Thus we cannot regard this disease and approach it 
only from a biomedical point of view and should not underestimate the approach 
to the psychosocial nature of the treatment. Biological, psychological, and social 
factors are interconnected, and imbalances in their complex interactions disrupt 
health and cause or worsen the disease. That is why it is necessary to create a 
so-called biopsychosocial comfort of an individual with SSc and to develop a 
number of activities in the sense of a complex treatment. This chapter focuses 
on the psychosomatic approach to health and illness and the development of the 
biopsychosocial model in medicine just as it should be used in patients with SSc.
Keywords: systemic sclerosis, biopsychosocial aspects, psychosocial aspects, 
psychosomatics, stress, non-pharmacological interventions
1. Introduction
Systemic sclerosis (SSc) is a disease in which fibrosis is one of the dominant 
pathological processes which affects the connective tissue, resulting in the involve-
ment of the skin, musculoskeletal system, and internal organs. It is a very hetero-
geneous and polymorphic disease, and in each individual the course and extent of 
the involvement is different. Most of the characteristic visceral organ involvement, 
such as interstitial lung disease, pulmonary arterial hypertension, and cardiac and 
gastrointestinal involvement, has a significantly negative effect on physical fitness 
and condition. This decreased level of physical condition neither benefits from the 
thickening and rigidity of the skin nor from muscle and tendon contraction and 
stiffness of the joints accompanied by pain and an ever-worsening range of motion 
in the joints [1, 2]. Furthermore, the mind itself, as a result of such a physical condi-
tion, is not helping these individuals, and together with the body condition, they 
aggravate the quality of life of SSc patients in a mutually interacting fashion. In line 
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with these principles, the healthcare professional’s approach should be also targeted 
toward the body and mind (or soul) of the individuals with SSc, and only then can 
the treatment be successful.
2. Systemic sclerosis and its impact on the body and soul
Systemic sclerosis is a rare, chronic, and potentially lethal disease character-
ized by microvascular disorder, immune system activation, autoimmunity, and 
increased deposition of extracellular matrix components in the skin and internal 
organs [1–3]. To date, many mechanisms involved in the pathogenesis of SSc remain 
unclear, but there is increasing evidence suggesting that it is a complex pathologi-
cal process, i.e., the interaction of the environment and genetic factors together 
with regulatory epigenetic mechanisms [1, 2, 4, 5]. Visceral organ involvement is 
responsible for increased mortality; however, in SSc patients, who are still alive, 
involvement of the lung, heart, skin, and musculoskeletal system poses a significant 
burden in terms of physical fitness and condition, as well as impairment of func-
tional ability and quality of life [6, 7].
Non-pharmacological care for patients with SSc is becoming an increasingly 
important part of the interest of clinical research in SSc and is likely to reduce 
disability and improve the quality of life while contributing to the reduction of 
the burden of the disease. Overall, such care is predominantly focused on the 
musculoskeletal system and the skin [8]. Besides the physical component in the 
treatment of SSc patients, we must not forget the psychological (emotional) 
component (i.e., soul or mind) and the social components. These components are 
greatly and very often underestimated in the treatment, considerably subjective 
and different every other day, and therefore very demanding in research setting, 
but very useful in routine clinical praxis, if we, physicians or healthcare profes-
sionals, address them.
Every day, the organism is exposed to the effects of various stressors against 
which it is trying to resist and adapt to, such as viruses, bacteria, toxins (heavy 
metals), drugs, physical and psychological stress and the resulting lack of sleep, 
infection, responsibility, sadness, hunger, injury, the disease itself, etc. Each of us 
has a different ability to resist these stressors and thus to train the organism in the 
fight against them. However, if the burden of stress exceeds the effort of our organ-
ism, it leads to maladaptation, which results in negative consequences. It affects the 
psychological and physical state as well as the basic regulatory systems (hormonal, 
immune, and nervous) and leads to the onset of the disease or exacerbation of the 
disease itself. At the same time, we need some degree of stress to keep these regula-
tory mechanisms in place, for which we have to compensate with a certain degree 
of rest. Balance is the basis of good physical and mental health. Inability to rest to a 
right extent and form is one of the major factors in the development or worsening 
of a disease. Unfortunately, this is usually underestimated in clinical routine, where 
the treatment approach often deals only with the physical consequences of the 
disease. The patient is regarded as an object, not an entity that has its own way and 
means to help itself. And to better understand this principle, it is vital to explain 
two main concepts: movement and stress [9, 10].
2.1 Movement—the pillar of life in health and illness
Movement is a basic feature of life, and its disorder is a source of both somatic 
and psychological difficulties and significantly influences the motor behavior of a 
person regarding its physical, mental, and social aspects. The metabolic, digestive, 
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excretory, hormonal, respiratory, and cardiac functions as well as reproductive 
organs also have a significant influence on movement behavior. However, the free 
movement itself is controlled by the nervous system [11]. Biocybernetics is a scien-
tific discipline dealing with the description of these control processes. Its main pur-
pose is to include different levels of living system information into a model enabling 
the understanding of the function of the living organism under physiological and 
pathological conditions, i.e., to split a human organism that is a complicated biologi-
cal system into simpler parts that can be more easily described and interpreted so 
that the organism can be readily understood as a whole rather than an isolated organ 
or subsystem [12]. Thus, a two-way exchange and processing of information is being 
conducted between the brain and the executive motor and internal organs. This 
constitutes a psychophysiological correlate that cannot be divided. To put it simply, 
the brain sends information to the muscles as motor instructions, and the executive 
body sends sensory information back to the brain to assure that the instructions were 
executed. Nevertheless, the state of mind and the way of thinking also influence 
the course of the whole movement [11]. It is said that all living organisms have the 
ability to perceive and respond to changes in the external and internal environment 
by sensory and motor sensors. These changes are being continuously read by our 
brain, processed, integrated, and interconnected with our emotions and then, at the 
cortical level, allow us to become conscious of them and understand them. In addi-
tion to all this, the connecting nociceptive component is also important, e.g., painful 
inputs, which in most pathological conditions are associated with disorders of 
emotional and cognitive pain processing [9, 11]. Thus, every type of physical move-
ment develops a specific type of reflective bodily consciousness that has a significant 
influence on how we feel our body and how we perceive the outside world. In other 
words, what we do with and to our bodies shapes the way we see and experience the 
world [13]. It is therefore important for contemporary science to perceive a person 
as a whole, i.e., as a functional unit, his soul (mind) and body, and in unity with 
the environment in which he lives. Furthermore, current science should limit the 
shortcomings in the sense of Descartes dualism, which is anchored in the history 
of medical knowledge and can be visible to this day [14, 15]. These two prevailing 
viewpoints in the treatment of an individual, body and soul, if they are apart from 
each other, are very limited. From the physical-mechanical point of view, it is a 
healing process that focuses on the physical structure of the organism and on the 
mechanics of movement at the site of the structure, and less attention is paid to other 
well-preserved structures. In this view, the mental influence on movement (caused 
by the developed disorder), considered to be a subjective accompaniment of move-
ment, is neglected in the objective analysis of the mechanics of motion. On the other 
hand, from a psychological point of view, it is a treatment procedure focused on the 
evaluation of the movement function affecting the formation of the organ structure, 
as well as on the personality character and its influence on the movement behavior, 
which can cause motor failure [11]. Both viewpoints during treatment emphasize a 
certain component of movement and do not separately meet the condition of a com-
prehensive treatment approach. Such a holistic treatment approach and procedure 
should include both of these components. In the treatment of an individual, it should 
be very beneficial to both sides, to the patient and the healer, and eventually to the 
whole system and economy. We are no robots, thus we should neither divide “soma” 
from “psyche” nor “psyche” from “soma,” neither in treatment nor in prevention.
2.2 Stress, our friend and foe
However, in order to maintain balance and life (movement, “psyche” and 
“soma”), it is important to adapt to various stressors acting on the living organism. 
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Despite the fact that ancient philosophers knew about stress and its effects, Hans 
Selye is considered to be the “father of stress.” His well-known concept of general 
adaptive syndrome (GAS) refers to three levels of biological response to stress: (a) 
alarm reaction stage (fight or flight), (b) resistance stage (adaptive), and (c) exhaus-
tion stage [16]. In his study of stress, Selye noted that patients with different illnesses 
had many of the same non-specific symptoms that were a common response to stress-
ful stimuli and that long-term stress exposure led to adaptation disorders. Although 
the GAS hypothesis was subsequently shown to be incorrect, it has put stress on the 
map and also emphasized that stress has a major impact on the immune system and 
on the adrenal glands [17–19]. In addition, epidemiological studies dealing with stress 
confirm the association between fetal malnutrition or poor nutrition in early life and 
coronary heart disease and constant changes in glucose metabolism, resulting in the 
development of diseases of civilization such as type 2 diabetes and myocardial infarc-
tion [20, 21]. Similarly, advances in studying genes, which increase the vulnerability 
of individuals to stressful life events, have attracted considerable research interest. 
For example, polymorphism in the monoamine oxidase A (MAOA) promoter that 
reduces MAOA expression affects vulnerability to environmental influences. This 
biological process can be initiated by childhood abuse. Furthermore, polymorphism 
in the serotonin transport gene promoter can also make individuals more prone to 
stressful life events [22–24]. At the same time, neuroendocrinology research revealed 
that the autonomic nervous system and hypothalamic–pituitary-adrenocortical 
(HPA) system serve as means of the afferent and efferent limbs of the stress response 
in vertebrates and are also central for maintaining homeostasis and allostasis [19]. 
Nevertheless, there is no unambiguous definition of stress but different perspectives 
depending on the studied field and different conditions. Stress is based on two basic 
concepts: physiological, non-specific (based on general knowledge), and psychologi-
cal, specific (based on the specifics of each individual). Thus we can say that stress 
is a universal concept that denotes any burden and any stress response leading to a 
violation of integrity, may it be supposed or true [25, 26]. According to Selye, stress 
is a non-specific (i.e., occurring stereotypically after a variety of stresses) physiologi-
cal response of the organism to any requirement applied to the organism. He argued 
that stress is not identical to emotional excitement or nervous tension because stress 
can occur during anesthesia in humans or animals and may also occur in plants and 
bacteria that do not have the nervous system [27, 28]. Criticism of this definition 
has been subjected to an experimental test that has shown that each stressor has its 
own specific neurochemical signature. Since these stress indexes are limited to only 
two neurohumoral systems and since most stressors have at least some overlapping 
responses, it is not clear that this approach degrades Selye’s definition. In addition, 
regardless of these limitations in the definition of Selye, cellular response to stress (in 
all living cells) is at molecular level represented by stress-induced synthesis of stress 
proteins or heat shock proteins (Hsps), of which molecular chaperones and proteases 
represent two well-characterized families. Many studies have shown that the response 
to heat shock is ubiquitous and highly conserved in all organisms from bacteria to 
plants and animals. It is a necessary defense mechanism for protecting cells (cyto-
protection) from a wide range of stressors, including heat shock, alcohols, ischemia, 
energy metabolism inhibitors, heavy metals, oxidative stress, fever, or inflamma-
tion that, depending on amplitude and duration, can cause cell death by apoptosis 
or necrosis. Hsps also serve as modulation signals for immune and inflammatory 
responses and may play a role in the production of cytokines [19].
Selye also assumed that if the psychosocial aspect is as important to a human 
being as a biological aspect, its influence will have the same strength and conse-
quences for the organism as biological factors. This has been later confirmed by new 
findings which demonstrate that psychological trauma has, in principle, analogous 
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consequences to physical trauma. Thus the stress model has become an important 
tool of psychosomatic approach [29].
Nowadays, there is a lot of research and growing interest in stress research focus-
ing on interactions between gene and environmental factors and the role of epi-
genetics and other mechanisms of gene control (e.g., RNA interference) in stress. 
This is also very important for research on rheumatic diseases, especially systemic 
sclerosis.
Systemic sclerosis is a disease, as we have indicated, where motion and locomo-
tion are restricted, and the disease itself is a stressor. Let alone the disease itself 
could be triggered by a stressor in a genetically predisposed individual.
So now it can be clear that the presence of tissue fibrosis in patients with SSc 
may adversely affect the transmission of information from receptors in the skin, 
muscles, joints, intestines, blood vessels, etc. This can consequently adversely affect 
the perception of internal and external changes, i.e., transmission, processing, 
and integration of information from internal and external environments, and the 
subsequent response of the patient with SSc, which is usually accompanied by pain 
and emotionally narratively experienced by the patient on an individual basis. Such 
a physical state can have a negative impact not only on the motor behavior of the 
SSc patient but also on the state of mind and the way of thinking which, conversely, 
have an impact on the course of movement, self-perception, and the surround-
ing environment. Adaptation of the organism in such a diseased condition is then 
weakened by various stressors, and its perceptions and interpretations may be 
unfavorable. The extent of dissatisfaction with a visibly changing person, not only 
for the patient but also for other people in his surrounding, the reaction of which 
the patient perceives very negatively, basically interferes with the personality of 
the patient and interpersonal relationships, self-esteem, self-image, self-efficacy, 
Figure 1. 
Biopsychosocial interactions in general population and systemic sclerosis.
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and socioeconomic position. To make the situation even more complicated, chronic 
fatigue; pain; disease-specific features, such as disease progression, severity, and 
related organ involvement; and subsequent reactive depression or anxiety greatly 
reduce the quality of life in SSc patients, as depicted in Figure 1.
2.3  Quality of life and its areas affecting the general condition of 
patients with SSc
As stated in the previous paragraph, there are a large number of symptoms 
accompanying SSc patients that affect the quality of life and are variably present on 
an individual basis, i.e., to a greater or smaller extent and with varying intensity and 
time course. All of them, however, have a negative impact on the entire biopsychoso-
cial personality of the individual and are influenced by a number of physical, psycho-
logical, and sociocultural factors. A recent analysis of a large Canadian study found 
that the most frequently reported symptoms (out of 65 possible symptoms with 
moderate to severe impact on activities of daily living) by SSc patients (more than 
450 in total) are fatigue (89–72%), Raynaud’s phenomenon (86–72%), hand stiff-
ness (81–59%), joint pain (81–64%), and sleep disorders (76–59%). Nevertheless, 
decreased hand function and joint and muscle pain have often been associated with a 
moderate to severe impact on daily activities. Fever, loss of appetite, weight loss, and 
reactive depression were also listed in the constitutional symptoms [30].
In a 2013 review of the studies on psychosocial aspects of SSc that were published 
in the literature following the publication of the Consensus Research Program in 
2010, which reflected the limitations of available studies in this area, researchers used 
structured interviews to determine the prevalence of clinical mood disorders in SSc. 
It has been found that anxiety remains understudied, and distress may be a useful 
outcome to consider. Predictors of fatigue and sexual dysfunction in men and women 
with SSc have been identified. Furthermore, body image distress suggests the impor-
tance of changes in the facial skin and hands, and breathing problems and fatigue 
predicted workplace disability. The study also found the importance of multidisci-
plinary care for the quality of life related to health. The truth remains that after the 
publication of this Consensus Research Program in 2010, the research methodology 
in the SSc psychosocial area has improved; nevertheless, there is still no prospective 
study in this field. Interventions need to be developed and tested through randomized 
controlled trials with the power to detect clinically meaningful changes [31].
Evidence-based medicine (EBM) of factors and symptoms subjectively expe-
rienced is always very limited due to the complexity and reliability of its research. 
This is especially true for rare diseases such as SSc. However, the subjective experi-
ence of any disorder plays an important role in the subsequent projection of the 
symptoms of the disease. When searched for in scientific databases, published 
studies are often evaluating the quality of life, depression, fatigue, or pain in SSc 
patients. Yet, we all, physicians or healthcare professionals, if we have listened to 
patients and had that holistic approach, have certainly met many patients who 
complained not directly about depression or the quality of life but especially on 
pain, fatigue, sleep disturbances, a certain movement, functional limitations and 
inability, fear of the future, suicidal tendencies, shame in the circle of their friends, 
mouth opening problems, inability to work, sexual dysfunction, issues associated 
with pregnancy, etc. In addition, their psychosocial problems resulting from this 
disease could even somatize. We are well aware of several other issues that may play 
a role: anxiety that is not just a feeling but a whole range of chemical processes; 
presence of larval depression; variability of pain and its perception based on every 
individual experience; some forms of pain that are also mediated by the so-called 
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My fingers curl and I cannot properly close the fist, thus everything is falling out. I cannot open a bottle of 
water
At work, I do not want to shake the customer’s hand. I could, but he would immediately notice and recognize 
that there is something wrong with my hands. That is why I am so ashamed of shaking people’s hands
When someone squeezes my hand, then it hurts, and I make a painful grimace. Then he immediately knows 
that there is something wrong with my hands and I am ashamed
I cannot point at someone with the raised index finger, or point up the thumb to show someone thumbs up, 
or to make high five with somebody
I cannot scratch my back, but at least I can still wipe my behind
My ability to write with a pen has deteriorated, and my signature is constantly changing, which has been 
noticed by the staff in the bank
My face feels like a mask, and I feel that people around me realize that there is something wrong with my 
face. I can also tell the difference from the reactions of men: earlier, when they met me, they changed their 
behavior, straightened up, and tried to make a contact with me. Now they look like they do not see me at all
My mouth and tongue are becoming tightened, therefore it is more difficult for me to articulate, and 
sometimes I am being misunderstood. I cannot stick my tongue out at anyone
My eyelashes are falling out, thus I cannot apply paint to my lashes
To go out with friends for a dinner? I could, but I usually do not order any food because I know I would feel 
sick. I cannot have a wine because of heartburn. When I drink a beer, it comes back and I have a full mouth of 
bubbles. However, I can still do shots. Thus I mostly look like a fool, because I can only order still water, and 
everyone is asking me with sympathy, why I cannot eat. And then they feel sorry for me. Sometimes a piece 
of food falls out of my mouth
When on vacation, I have a problem eating at the hotel. Since my lungs are affected I cough every morning. 
When I go for a breakfast and start coughing, everyone looks at me and thinks I have tuberculosis or at least a 
contagious infection. Similarly, I get the same awkward feeling when traveling by a subway, bus or airplane. 
Usually I cannot eat much for dinner
I am not fit and able to climb a small hill
I cannot drink using a straw, whistle or lick my lips
My dentist is hysterical when he sees me. My teeth never used to decay easily, but now, even if I clean them 
very carefully, they do. I still have all four wisdom teeth and the dentist is afraid of repairing or extracting 
them since he cannot access them properly
When I had my picture taken for a new ID, I smiled a little. The clerk was making fun of me. I did not 
know why. Then he showed me the photo, if it was okay. I had a skewed smile. I told him that I always have 
a symmetrical smile, and that he should take a new photo. However, it was the same. When he did it once 
again, I eventually believed I looked this way
Because my esophagus is affected by scleroderma, I have to sleep in a semi-seated position, which is hard to 
organize in a hotel, which usually has a problem to get so many pillows for me. Thereafter, in the morning I 
walk hunched over from back pain
It annoys me when my friends, who have not seen me for a week, ask me, how I am doing. If my illness has 
improved. It bothers me when they feel sorry for me. I’d rather never have to meet anyone
I do not like to go anywhere, although prior to my illness, I could not stand it being without other people
My boyfriend left me because I could not satisfy him manually, orally, or vaginally. I’d rather die
Will my disease get worse when I deliver my baby?
I do not trust the doctors. I blame the contraception pills for triggering my illness
I have no friends anymore, because my physical condition is not what it used to be. They do not want to wait 
for me. When we should go outside for a walk, they rather say that they do not want to burden me, and that I 
should stay at home
I have two little children and I am afraid I will not be able to take care of them sooner or later. My husband 
left me
I am unable to work and am not financially secure. When I say I have a disease, no one wants to hire me
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hidden central nervous system defects; chronic pain which always accompanies a 
change in behavior that often complicates and prolongs the course of the disease; 
some emotional or social problems which cannot be read well and are erroneously 
processed by a patient and then they are experienced in a physical form, etc. [9].
From my own experience, I particularly depict a few points of subjective experi-
ence in a few selected sentences articulated by the majority of more than 150 SSc 
patients during my 7-year practice that can be exhaustive for us healthcare profes-
sionals, but, on the other hand, they depict the everyday nightmare of patients with 
SSc (Table 1). This suggests that, aside from the EBM, SSc patients, if we listen 
to them, have psychological, emotional, social, and socioeconomic problems that 
should not be overlooked, because if they are not addressed, each of our treatment 
approach is wrong and we will not achieve the desired result. Thus, it is not enough 
just to direct the treatment in a biomedical manner, but it is necessary to aim, more 
extensively and as soon as possible, for the so-called biopsychosocial comfort of an 
individual. Therefore, interdisciplinary cooperation and the development of a num-
ber of activities in the area of complex rehabilitation are necessary in order to bring 
its significance to the attention of the wider medical community so that it becomes a 
necessary part of the treatment of patients with SSc in clinical practice.
3. Biopsychosocial model of the treatment of patients with SSc
Contemporary medicine should evolve to the ideal of a biopsychosocial (BPS) 
approach, i.e., psychosomatic treatment of patients, let alone its research. Because 
I have an affected esophagus and lungs, and digestive problems too. Other than that I do not look as a sick 
person. My biggest problem is fatigue, due to which I cannot normally function. Everyone thinks I am 
malingering. I have no support and I am in it on my own, and thinking about committing suicide
People are avoiding me
My breasts are gone
My skin is itching terribly and my face is full of small red spots
My skin color is changing, I look terrible
I cannot look in the mirror at myself anymore. It is not me.
There are only few specialists dealing with this disease and my doctor is very passive. I have to tell him what 
to prescribe
I live in countryside, and there is no physiotherapist available who could help me
I am not interested in any groups of patients with this disease. On one hand, they scare me, on the other 
hand, I feel alone. I want my normal life back. Will I ever have my old life back? Can I be healed?
I have researched this disease in the internet, where I found information that I would die within next 5 years. 
Is that true? If yes, I’d rather kill myself right now
On Facebook, I have read that stem cell transplantation can heal my disease. Is that true?
Do you think that alternative methods can help me? I have spent a lot of money already, and nothing has 
changed. What should I do? I do not want to die
I am unable to catch a bus or tram, since I cannot run, my lungs do not allow it. I am stiff, in pain and slow
What, do you think, would help you most in the treatment of your disease? Patients’ answers: rest, option, 
freedom, peace, absence of introversion, contact with other people, experience, divorce, etc. (none of the 
patients said or thought about any potential new or existing drug!!!)
Table 1. 
List of a few selected authentic sentences from the point of view of patients with SSc, which emphasize the need 
for a biopsychosocial model of the treatment of patients with SSc (from the author’s own long-term experience 
with approximately 150 patients with SSc).
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not just one, but all three factors (not separating emotions either), as we have 
suggested, precede some malfunction, experience, progression, and prognosis. In 
other words, “psyche” and “soma” form an integral and functional inseparable unit. 
Although in 1977 the World Health Organization (WHO) adopted a BPS model of 
illness involving biological, psychological, and social factors, which aims to extend 
the vision of a physician to psychosocial contexts, and to apply its practical use in 
everyday practice, there is still a long journey to a BPS model of treatment. It is due 
to the fact that one of the factors of increasing imbalance disfavoring psychosocial 
factors in ailing, besides its considerable complexity, can be the EBM methodology 
itself, which still favors biological factors in obtaining evidence of the correctness 
of the treatment [32]. The need for the BPS model of treatment was pointed out 
by Engel in the 1970s and 1980s [33, 34], who argued that the biomedical model 
of treatment does not take into account the psychosocial aspects of health and 
illness. He explained it by the fact that other factors (such as subjective experience 
of illness) that affect social, psychological, and cultural variables also interfere 
with biochemical responses and they need to be assessed in a view of their interac-
tion with each other. Engel did not deny the importance of biomedical research in 
medicine, but criticized the too narrow (biomedical) focus of leading clinicians 
who see patients as objects and ignore the possibility that subjective patient experi-
ence is accessible to a scientific study. He promoted his ideas not only as a scientific 
proposal but also as a basic ideology that tried to reverse the dehumanization of 
medicine and the disarmament of patients. Furthermore, his research in psycho-
somatics has pointed to an integrative view, showing that fear, fury, neglect, and 
attachment have physiological and developmental effects on the whole organism 
[35]. According to him, the BPS model is a complex and systemic view of relation-
ships that affect both health and illness both inside and outside the individual [36].
On the contrary, critics of the Engel’s BPS model support Grinker’s approach, 
which highlights biological factors that were otherwise ignored, especially in mental 
illnesses [36]. According to Monet and Lazarus, the BPS model is based on a stress 
theory that has a psychological and physiological level including the level of the 
environment [37]. And, according to Junne and Zipfe, there is a need for an inter-
connected biomedical and biopsychosocial approach and interdisciplinary coopera-
tion [38]. Some authors think that the BPS model has helped patients to make better 
use of existing knowledge than the science itself in medicine [35]. Nevertheless, in 
1977, the BPS model of illness was adopted by the WHO, which at the same time 
defined health as “a state of complete physical, mental and social well-being, and 
not merely the absence of disease or infirmity” [39].
Indeed, the definition is clearly indicated by the fact that if we want to heal or 
approach a healthy condition, an individual with SSc (or any other individual) must 
concentrate on maintaining a balance between these mutually affecting factors, 
which also jointly influence the onset, progression, and prognosis of the disease, its 
outcomes, and mortality of SSc patients. Biological factors in SSc comprise microvas-
cular involvement of unknown etiology, immune activation, and progressive tissue 
fibrosis against which there is no universal effective drug available to date. In addition, 
more and more evidence points to a close link between environmental factors and the 
pathogenesis of SSc, i.e., the complete pathological process of interacting with the 
environment and genetic factors that corresponds to epigenetic mechanisms [3].
At the same time, fatigue, depression or anxiety, body image distress, pain, 
functional limitation, decreased quality of life, and disturbance of sleep patterns 
were noted among the main psychosocial factors influencing the adaptation to this 
chronic illness [31, 40–46]. Furthermore, from our own experience, in the history 
of patients, we can identify factors that precede the onset of the disease, namely, 
exposure to stressors and environmental factors, poor lifestyle or social support 
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(family, society, and community), personality, emotional incompetence, etc. The 
question remains: Who is responsible for the treatment and resolution of these 
factors? The physician? Physiotherapist? Psychologist? Gynecologist? Sexologist? 
Occupational therapist? Social worker? Or some other healthcare professional? 
In the BPS model of treatment, the answer is clear—interdisciplinary coopera-
tion which is very demanding but beneficial. And if there is no interdisciplinary 
cooperation, all of these factors (because these patients usually have them) fall into 
the care of one expert, who can experience a burnout or ignorance syndrome from 
exhaustion and great exertion and misunderstanding of all the components.
Unfortunately, the current concept of medicine addresses most of the patients (let 
alone patients with a rare and incurable disease like SSc) as an object from a biomedi-
cal point of view, assuming the linear relationship between the pathophysiology of 
the disease, its course, the patient’s involvement, and disability, whose usual means of 
treatment are insufficiently effective. This is also the case if healing does not take place 
in a multidisciplinary team and the psychosocial factors affecting the ability of patients 
with SSc to face their disease are neglected and underestimated due to the idea that 
they belong to other professionals competent in this area. In addition, possible soma-
tized psychosocial problems caused by this disease in SSc patients, who respect a physi-
cian who performs a social role for them which equals the position of God, strengthen 
this biomedical model most of the time. On the other hand, the psychosocial model 
assumes that the interdependence between the bio-, psycho-, and social variables is 
rather complex and therefore the SSc can be understood as a significant predictor of 
a mental condition. This is how we can say that such an integrated BPS model of SSc 
includes both the effects that contribute to the progression of the disease but also the 
influences involved in the disease behavior. However, none of the processes is linear but 
involves circular cycle and feedback with a repeating process over time [47–49].
From my own experience, I can point out that during the diagnosis process and 
subsequent treatment, the patient with SSc suffers from several stages of disease 
acceptance: from shock upon diagnosis, detection of its prognosis on inadequate 
web sites, anxiety states at the time of first physical symptoms and increased 
follow-up, inappropriate expectation of the results of further examinations to 
a depressive state of varying intensity. Another response is deciding whether to 
undergo treatment at all if there is no universal effective drug, and the drugs used  
to suppress the symptoms of the disease have many other undesirable and poten-
tially toxic effects on the body. Consequently, some even experience maladaptation, 
refusal of treatment, and accompanying deep depression with suicidal thoughts. 
Nevertheless, the patient is constantly confronted with the reality of decreased life 
expectancy (70% of SSc patients survive for 10 years), the fear of pain, change in 
appearance, functional limitation, dependence on another person, loneliness, lack 
of social support, cessation of many activities, fear of treatment side effects, death, 
etc. Cognitive assessment of threats created by stressors and other possible sources 
has a central role in the effects of stressors on psychosocial and somatic outcomes.
In a 2014 study, where a personalized approach was used for modeling bio-
psychosocial features in relation to SSc-associated pain, the results indicated that 
psychosocial functioning is the basis for understanding the pain in this population, 
and physicians should apply the holistic approach and, if appropriate, recommend 
pain management in specialized centers [49].
And such a complex BPS model in SSc patients offers a comprehensive approach 
to diagnosis and treatment of its manifestations, including pain that mostly leads to 
suffering. However, suffering through somatization can also create pain, influenced 
by cognitive and emotional factors. This means that for a SSc patient, social and 
psychological impairment as a result of painful experience can be as difficult as 
somatic injury.
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4. Conclusion
In conclusion, we can say that without the need to investigate EBM, an indi-
vidual complex of biopsychosocial factors influences the onset, progression, 
treatment, and survival of SSc patients. In addition, besides the biological factors, 
the psychological and social factors play a significant role in negatively affecting the 
quality of life of patients with SSc and their interpersonal relationships, disruption 
and change of their personality and behavior, and coping with the illness. Since the 
illness and the consequences of treatment are reflected and manifested not only at 
the somatic level but also at psychological (emotional) and social levels, we should 
consider all these components in the treatment and approach in a multidisciplinary 
fashion. Since fatigue is one of the most prevalent symptoms which is adversely 
affecting the SSc patients, future research should investigate whether such a 
disease-associated depressive condition negatively promotes fatigue or whether 
effective pain management could reduce fatigue or explore other possible causes 
of fatigue and then find adequate strategies for its effective management. In any 
case, anyone involved in the treatment of SSc patients should have that twenty-first 
century holistic approach, take a proper medical history, and listen to patients’ own 
opinions about their quality of health, which could help to spread the knowledge 
about psychosomatic correlations of the disease and adequate modification of 
the therapy for the patient. Nevertheless, proper education and awareness of the 
patient’s illness is essential in managing the illness according to the best practice 
available.
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